© 2023 Pfizer Inc. All rights reserved. Printed in the USA
PP-PBI-USA-0017 November 2023
Please see Brief Summary of Prescribing Information on
the following pages and full Prescribing Information for
PENBRAYA at PENBRAYAhcp.com.
Now you can help protect against the 5 leading meningococcal serogroups (A, B, C, W, and Y)
with PENBRAYA, the first and only pentavalent (5-in-1) vaccine to provide
the broadest protection with the fewest injections.
1-4
*
Scan the code to learn more at PENBRAYAhcp.com
References: 1. PENBRAYA [prescribing information]. New York, NY: Pfizer Inc.; 2023. 2. Vaccines and preventable diseases:
meningococcal vaccination. Centers for Disease Control and Prevention. Last reviewed October 12, 2021. Accessed
August 2, 2023. https://www.cdc.gov/vaccines/vpd/mening/index.html 3. Recommended child and adolescent immunization
schedule for children and adolescents aged 18 years or younger. Centers for Disease Control and Prevention. Published
September 25, 2023. Accessed October 21, 2023. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-
combined-schedule.pdf 4. Purmohamad A, Abasi E, Azimi T, et al. Global estimate of Neisseria meningitidis serogroups
proportion in invasive meningococcal disease: a systematic review and meta-analysis. Microb Pathog. 2019;134:103571.
*One less injection required compared to administering separate MenACWY and MenB vaccines at the same time.
1,3
5-IN-1 PROTECTION 5-IN-1 PROTECTION
against against
MENINGOCOCCAL DISEASE MENINGOCOCCAL DISEASE
1
NOW APPROVED
1
